Encompass Health (EHC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
7 May, 2026Opening remarks and agenda
Meeting called to order with introductions of board members and executive management in attendance.
Agenda and rules of conduct referenced, with voting procedures explained for stockholders.
Confirmation that proxy materials and meeting notice were mailed to stockholders of record.
Board and executive committee updates
All board members standing for election were introduced, including the President and CEO.
Executive Vice Presidents for operations and finance, as well as representatives from the auditing firm, were present.
Shareholder proposals
No director nominations were received from stockholders for this meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Encompass Health
- Q3 growth lifted results and FY26 guidance amid expansion and payer uncertainties.EHC
Q3 2026 - FY growth and stronger cash flow support 2024 revenue and EBITDA expansion targets.EHC
Q4 2023 - Q2 2026 revenue and EPS rose sharply, with raised guidance and expanded buyback plans.EHC
Q2 2026 - Sustained growth, disciplined cost management, and strategic expansion drive strong performance.EHC
Barclays 27th Annual Global Healthcare Conference - Strong volume growth, targeted expansion, and disciplined capital management drive performance.EHC
Bank of America Global Healthcare Conference 2026 - Q1 2026 saw strong revenue, EBITDA, and net income growth, driving higher full-year guidance.EHC
Q1 2026 - Virtual annual meeting to elect directors, ratify auditor, and approve performance-based executive pay.EHC
Proxy filing - Expansion, innovation, and disciplined capital use drive positive outlook and operational momentum.EHC
Barclays 28th Annual Global Healthcare Conference - Q4 2024 saw robust growth in revenue, earnings, and cash flow, with a strong 2025 outlook.EHC
Q4 2024